Advertisement
Actualités Forex
Amazon Says Customers Saved Nearly 70% More During 11 Days Of Deals
Amazon.com, Inc. (AMZN) announced Tuesday that its extended Black Friday and Cyber Monday holiday shopping event, which kicked off November 17 and continued through November 27, was its biggest ever compared to the same 11-day period ending on Cyber Monday in previous years.
RTTNews |
il y a 561
Quest, Scipher Team Up To Expand Diagnostic Services Access For Patients With Rheumatoid Arthritis
Diagnostic services provider Quest Diagnostics (DGX) and precision immunology company Scipher Medicine announced Tuesday a multi-pronged collaboration designed to expand patient access to diagnostic services advancing precision medicine for rheumatoid arthritis (RA).
RTTNews
|
il y a 561
Canadian Dollar Advances On Higher Oil Prices
The Canadian dollar strengthened against its major counterparts in the European session on Tuesday, as oil prices rose on hopes that OPEC+ may deepen and extend output cuts into next year.
RTTNews
|
il y a 561
Carpenter Technology Promotes Brian Malloy To COO
Carpenter Technology Corp. (CRS) announced Tuesday Brian Malloy has been named Senior Vice President and Chief Operating Officer, effective December 4, 2023. He will continue to report directly to Tony Thene, President and Chief Executive Officer.
RTTNews
|
il y a 561
Electra Battery, Rock Tech Ink Lithium Recycling MOU To Upgrade To Battery-grade Lithium Chemicals
Electra Battery Materials Corp. (ELBM, ELBM.V) on Tuesday signed a memorandum of understanding with lithium development company Rock Tech Lithium (RCK.V) for the development of a partnership to supply recycled lithium from Electra's Ontario battery recycling operations for upgrading to battery-grade lithium chemicals in Rock Tech's lithium refineries.
RTTNews
|
il y a 561
PDS Biotechnology Appoints Lars Boesgaard To Succeed Matthew Hill As CFO
Immunotherapy company PDS Biotechnology Corp. (PDSB) announced Tuesday the appointment of Lars Boesgaard as Chief Financial Officer (CFO), effective as of December 4, 2023.
RTTNews
|
il y a 561
Chart Industries Introduces Medium-term Financial Targets Through 2026
Ahead of its Investor Day later on Tuesday, engineering design firm Chart Industries, Inc. (GTLS) will introduce medium-term financial targets through 2026.
RTTNews
|
il y a 561
more news
FTSE 100 Extends Losses As Inflation Focus Weighs
FTSE 100 of the London Stock Exchange slipped more than a quarter percent, in line with its European peers even as markets reconciled with the prospect of central banks persisting with the inflation combat strategy.
RTTNews
|
il y a 561
Bay Street May Open With Positive Bias
Canadian shares are likely to open with a slightly positive bias Tuesday morning, tracking higher crude oil and gold prices. However, with a slew of crucial economic data from Canada, the U.S. and China due during the course of this week, the mood is likely to remain cautious once again.
RTTNews
|
il y a 561
Toyota Motor North America Expects Arrival Of 2024 I-FORCE Tacoma In Toyota Dealerships In December
Toyota Motor North America announced Tuesday that it expects the arrival of the completely redesigned all-new 2024 i-FORCE Tacoma at Toyota dealerships in December 2023. The i-FORCE MAX models are expected to arrive in the spring of 2024.
RTTNews
|
il y a 561
EasyJet Stock Up On FY23 Profit, Positive Outlook
Shares of EasyJet Plc were gaining more than 3 percent in the trading in London after the British low-cost airliner on Tuesday reported a profit for fiscal 2023, compared to prior year's loss, with significant contribution from easyJet holidays and strong growth in demand. Looking ahead, the company said fiscal 2024 has begun positively with strong year-on-year profit growth in October.
RTTNews
|
il y a 561
CAC-40 Declines Amidst Concerns About Inflation, China Growth
The CAC-40 benchmark slipped in Tuesday's trade amidst concerns about inflation ahead of release of latest readings.
RTTNews
|
il y a 561
Avidity Biosciences Inks Global Licensing And Research Collaboration Deal With Bristol Myers Squibb
Biopharmaceutical company Avidity Biosciences, Inc. (RNA) announced Tuesday a global licensing and research collaboration with Bristol Myers Squibb (BMY) focused on the discovery, development and commercialization of multiple cardiovascular targets with potential cumulative payments of up to $2.3 billion.
RTTNews
|
il y a 561
Stay up to date!
Add Actualités to your browser
Add To Chrome
